Momenta Pharmaceutical (MNTA -5.7%) takes a hit after UBS downgraded the shares to Neutral...

|About: Momenta Pharmaceuticals, Inc. (MNTA)|By:, SA News Editor

Momenta Pharmaceutical (MNTA -5.7%) takes a hit after UBS downgraded the shares to Neutral earlier this morning, citing limited near-term catalysts and cash burn following the recent negative court ruling in the Copaxone case. The firm retains its price target of $15.